Table S1 - Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
收藏数据链接：
官方服务：
资源简介：
Summary of regimens supported by the literature. (DOCX)
创建时间：
2015-12-02
